Physician

Adil Jamal Akhtar, M.D.

According to 2025 Medicare claims, Adil Akhtar, M.D. (NPI: 1609829001) practices medical oncology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Macomb, MI. This provider's primary affiliated billing organization is MICHIGAN HEALTHCARE PROFESSIONALS PC (NPI: 1295023547; TIN: 451674932) and primary practice location at 48314-9998. Akhtar is affiliated with the Honest ACO of Michigan LLC (ACO ID: D0236), participating under the REACH model.

Akhtar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 335 traditional Medicare patients, billed 10,181 HCPCS/CPT codes, and received $235,980 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 85 prescription claims across 34 beneficiaries totaling $159,525 in drug costs, led by Exemestane (Exemestane). 2022 DME data shows 15 claims. Open Payments data shows 2 records totaling $36. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $336,712 and ending at $235,980. Concurrently, Part D prescription costs have fallen sharply in recent years, from $665,878 to $159,525. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	440	16,207	$336,712
2016	398	24,589	$349,507
2017	429	37,231	$468,378
2018	507	35,283	$627,762
2019	694	77,888	$1,563,716
2020	698	109,016	$1,795,090
2021	671	71,413	$1,247,747
2022	648	102,596	$1,447,415
2023	449	30,230	$433,134
2024	335	10,181	$235,980

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	178	599	$665,878
2016	109	388	$622,831
2017	95	342	$313,061
2018	106	417	$441,381
2019	115	496	$632,136
2020	115	495	$1,210,994
2021	109	463	$1,234,229
2022	133	582	$1,717,635
2023	78	279	$1,075,171
2024	34	85	$159,525

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	29	$1,722
2020	N/R	25	$2,101
2021	N/R	59	$3,654
2022	N/R	15	$191
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	55	55	$170
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	32	35	$145
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	134	144	$138
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	124	321	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	32	39	$91

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Exemestane	Exemestane	15	690	$4,243
Letrozole	Letrozole	14	1,140	$1,746
Omeprazole	Omeprazole	12	600	$71

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$36	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adil Jamal Akhtar, M.D.?

Tedicare shows public-source Medicare data for Adil Jamal Akhtar, M.D. (NPI 1609829001), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adil Jamal Akhtar, M.D. have ACO affiliation data?

Adil Jamal Akhtar, M.D. is shown with ACO affiliation data for Honest ACO of Michigan LLC (REACH, ACO ID D0236).

What billing organization is linked to Adil Jamal Akhtar, M.D.?

Adil Jamal Akhtar, M.D. is linked to MICHIGAN HEALTHCARE PROFESSIONALS PC (billing NPI 1295023547) in the available physician profile data.

Does Adil Jamal Akhtar, M.D. have Open Payments data?

Adil Jamal Akhtar, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.